Follow
Ciro Celsa
Ciro Celsa
MD, Section of Gastroenterology, Department of Health Promotion, Mother and Child Care, Internal
Verified email at community.unipa.it
Title
Cited by
Cited by
Year
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
G Cabibbo, C Celsa, V Calvaruso, S Petta, I Cacciola, MR Cannavò, ...
J Hepatol 71 (2), 265-273, 2019
185*2019
Association between PNPLA3 rs738409 C> G variant and liver-related outcomes in patients with nonalcoholic fatty liver disease
S Grimaudo, RM Pipitone, G Pennisi, C Celsa, C Cammà, V Di Marco, ...
Clinical Gastroenterology and Hepatology 18 (4), 935-944. e3, 2020
1372020
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis
V Sapena, M Enea, F Torres, C Celsa, J Rios, GEM Rizzo, P Nahon, ...
Gut 71 (3), 593-604, 2022
852022
Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
A Vitale, G Cabibbo, M Iavarone, L Viganò, DJ Pinato, FR Ponziani, Q Lai, ...
The Lancet Oncology 24 (7), e312-e322, 2023
762023
Diagnostic performance of endoscopic ultrasound through‐the‐needle microforceps biopsy of pancreatic cystic lesions: Systematic review with meta‐analysis
M Tacelli, C Celsa, B Magro, M Barchiesi, L Barresi, G Capurso, ...
Digestive Endoscopy 32 (7), 1018-1030, 2020
752020
Antidiabetic drugs in NAFLD: the accomplishment of two goals at once?
M Tacelli, C Celsa, B Magro, A Giannetti, G Pennisi, F Spatola, S Petta
Pharmaceuticals 11 (4), 121, 2018
642018
Efficacy of lumen-apposing metal stents or self-expandable metal stents for endoscopic ultrasound-guided choledochoduodenostomy: a systematic review and meta-analysis
A Amato, E Sinagra, C Celsa, M Enea, A Buda, F Vieceli, L Scaramella, ...
Endoscopy 53 (10), 1037-1047, 2021
572021
Dynamic angiopoietin-2 assessment predicts survival and chronic course in hospitalized patients with COVID-19
E Villa, R Critelli, S Lasagni, A Melegari, A Curatolo, C Celsa, ...
Blood advances 5 (3), 662-673, 2021
552021
Risk factors for rate of relapse and effects of steroid maintenance therapy in patients with autoimmune pancreatitis: systematic review and meta-analysis
M Tacelli, C Celsa, B Magro, L Barresi, S Guastella, G Capurso, L Frulloni, ...
Clinical Gastroenterology and Hepatology 17 (6), 1061-1072. e8, 2019
552019
AGILE 3+ score for the diagnosis of advanced fibrosis and for predicting liver-related events in NAFLD
G Pennisi, M Enea, A Pandolfo, C Celsa, M Antonucci, C Ciccioli, ...
Clinical Gastroenterology and Hepatology 21 (5), 1293-1302. e5, 2023
532023
The burden of hepatocellular carcinoma in non-alcoholic fatty liver disease: screening issue and future perspectives
G Pennisi, C Celsa, A Giammanco, F Spatola, S Petta
International journal of molecular sciences 20 (22), 5613, 2019
532019
Biliary complications after liver transplantation: current perspectives and future strategies
B Magro, M Tacelli, A Mazzola, F Conti, C Celsa
Hepatobiliary Surgery and Nutrition 10 (1), 76, 2021
502021
First-line immune checkpoint inhibitor-based sequential therapies for advanced hepatocellular carcinoma: rationale for future trials
G Cabibbo, M Reig, C Celsa, F Torres, S Battaglia, M Enea, GEM Rizzo, ...
Liver Cancer 11 (1), 75-84, 2022
402022
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
F Caputo, V Dadduzio, F Tovoli, G Bertolini, G Cabibbo, K Cerma, ...
PLoS One 15 (5), e0232449, 2020
402020
Real-life clinical data of lenvatinib versus sorafenib for unresectable hepatocellular carcinoma in Italy
V Burgio, M Iavarone, GG Di Costanzo, F Marra, S Lonardi, E Tamburini, ...
Cancer Management and Research, 9379-9389, 2021
382021
Pharmacological therapy of non-alcoholic fatty liver disease: What drugs are available now and future perspectives
G Pennisi, C Celsa, F Spatola, M Dallio, A Federico, S Petta
International Journal of Environmental Research and Public Health 16 (22), 4334, 2019
352019
Predicting in-hospital mortality from Coronavirus Disease 2019: A simple validated app for clinical use
B Magro, V Zuccaro, L Novelli, L Zileri, C Celsa, F Raimondi, M Gori, ...
PloS one 16 (1), e0245281, 2021
342021
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: A systematic review with meta-analysis of aggregate and individual data
M Tacelli, N Bina, SF Crinò, A Facciorusso, C Celsa, AS Vanni, A Fantin, ...
Gastrointestinal Endoscopy 96 (6), 898-908. e23, 2022
332022
Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE)
V Zuccaro, C Celsa, M Sambo, S Battaglia, P Sacchi, S Biscarini, ...
Scientific reports 11 (1), 1137, 2021
322021
Hepatectomy versus sorafenib in advanced nonmetastatic hepatocellular carcinoma: a real-life multicentric weighted comparison
S Famularo, M Donadon, F Cipriani, F Giuliante, S Ferri, C Celsa, ...
Annals of Surgery 275 (4), 743-752, 2022
292022
The system can't perform the operation now. Try again later.
Articles 1–20